Veracyte, Inc. VCYT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 31.50M | 25.49M | 28.71M | 41.15M | 19.14M |
| Total Depreciation and Amortization | 5.98M | 4.84M | 5.43M | 5.30M | 5.27M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.58M | 13.76M | 12.81M | 658.00K | 15.90M |
| Change in Net Operating Assets | 1.19M | 1.74M | -11.73M | 5.48M | 4.45M |
| Cash from Operations | 40.26M | 45.83M | 35.22M | 52.58M | 44.76M |
| Capital Expenditure | -2.33M | -2.86M | -2.96M | -3.78M | -2.79M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -153.19M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -2.85M | -- |
| Other Investing Activities | 16.05M | -10.69M | -125.00M | 1.20M | 51.06M |
| Cash from Investing | -139.47M | -13.55M | -127.96M | -5.43M | 48.26M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.33M | 8.43M | 2.74M | 3.51M | 5.79M |
| Repurchase of Common Stock | -3.80M | -4.29M | -9.36M | -3.66M | -2.81M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -479.00K | 4.14M | -6.63M | -149.00K | 2.98M |
| Foreign Exchange rate Adjustments | -18.00K | -26.00K | -58.00K | 12.00K | 60.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -99.71M | 36.39M | -99.43M | 47.02M | 96.06M |